Concurrent Chemoradiation with Low-Dose Weekly Cisplatin in Locally Advanced Stage IV Head and Neck Squamous Cell Carcinoma

논문상세정보
' Concurrent Chemoradiation with Low-Dose Weekly Cisplatin in Locally Advanced Stage IV Head and Neck Squamous Cell Carcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • chemoradiotherapy
  • cisplatin
  • head and neck neoplasms
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,415 0

0.0%

' Concurrent Chemoradiation with Low-Dose Weekly Cisplatin in Locally Advanced Stage IV Head and Neck Squamous Cell Carcinoma' 의 참고문헌

  • Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer : the Baskent University experience
    Kose F Asian Pac J Cancer Prev 12 : 1185 ~ 1188 [2011]
  • Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer : the Baskent University experience
    Kose F Asian Pac J Cancer Prev 12 1185-1188 [2011]
  • Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer
    Espeli V Oral Oncol 48 : 266 ~ 271 [2012]
  • Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer
    Espeli V Oral Oncol 48 266-271 [2012]
  • Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck : a prospective randomized trial
    Jeremic B Radiother Oncol 43 : 29 ~ 37 [1997]
  • Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck : a prospective randomized trial
    Jeremic B Radiother Oncol 43 29-37 [1997]
  • Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
    Cooper JS N Engl J Med 350 : 1937 ~ 1944 [2004]
  • Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
    Cooper JS N Engl J Med 350 1937-1944 [2004]
  • Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
    Chan AT J Natl Cancer Inst 97 : 536 ~ 539 [2005]
  • Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
    Chan AT J Natl Cancer Inst 97 536-539 [2005]
  • Global cancer statistics, 2002
    Parkin DM CA Cancer J Clin 55 : 74 ~ 108 [2005]
  • Global cancer statistics, 2002
    Parkin DM CA Cancer J Clin 55 74-108 [2005]
  • Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer : an RTOG analysis
    Machtay M J Clin Oncol 26 : 3582 ~ 3589 [2008]
  • Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer : an RTOG analysis
    Machtay M J Clin Oncol 26 3582-3589 [2008]
  • Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients
    Otty Z Asia Pac J Clin Oncol 7 : 287 ~ 292 [2011]
  • Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients
    Otty Z Asia Pac J Clin Oncol 7 287-292 [2011]
  • Dose intensity comparison between weekly and 3-weekly cisplatin delivered concurrently with radical radiotherapy for head and neck cancer : a retrospective comparison from New Cross Hospital, Wolverhampton, UK
    Ho KF Acta Oncol 47 : 1513 ~ 1518 [2008]
  • Dose intensity comparison between weekly and 3-weekly cisplatin delivered concurrently with radical radiotherapy for head and neck cancer : a retrospective comparison from New Cross Hospital, Wolverhampton, UK
    Ho KF Acta Oncol 47 1513-1518 [2008]
  • Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck : an RTOG Study
    Al-Sarraf M Cancer 59 : 259 ~ 265 [1987]
  • Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck : an RTOG Study
    Al-Sarraf M Cancer 59 259-265 [1987]
  • Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
    Forastiere AA N Engl J Med 349 : 2091 ~ 2098 [2003]
  • Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
    Forastiere AA N Engl J Med 349 2091-2098 [2003]
  • Concomitant weekly cisplatin and radiotherapy for head and neck cancer
    Homma A Jpn J Clin Oncol 41 : 980 ~ 986 [2011]
  • Concomitant weekly cisplatin and radiotherapy for head and neck cancer
    Homma A Jpn J Clin Oncol 41 980-986 [2011]
  • Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy
    Huguenin P J Clin Oncol 22 : 4665 ~ 4673 [2004]
  • Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy
    Huguenin P J Clin Oncol 22 4665-4673 [2004]
  • Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer : the University of Wisconsin experience
    Traynor AM Head Neck 32 : 599 ~ 606 [2010]
  • Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer : the University of Wisconsin experience
    Traynor AM Head Neck 32 599-606 [2010]
  • Chemotherapy added to locoregional treatment for head and neck squamouscell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer
    Pignon JP Lancet 355 : 949 ~ 955 [2000]
  • Chemotherapy added to locoregional treatment for head and neck squamouscell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer
    Pignon JP Lancet 355 949-955 [2000]
  • Chemoradiotherapy with weekly cisplatin 40 mg/m(2)in 103 head-andneck cancer patients : a cumulative dose-effect analysis
    Steinmann D Strahlenther Onkol 185 : 682 ~ 688 [2009]
  • Chemoradiotherapy with weekly cisplatin 40 mg/m(2)in 103 head-andneck cancer patients : a cumulative dose-effect analysis
    Steinmann D Strahlenther Onkol 185 682-688 [2009]
  • An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
    Adelstein DJ J Clin Oncol 21 : 92 ~ 98 [2003]
  • An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
    Adelstein DJ J Clin Oncol 21 92-98 [2003]
  • A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
    Budach W BMC Cancer 6 : 28 ~ [2006]
  • A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
    Budach W BMC Cancer 6 28- [2006]